PORTENT - Evaluation and Validation of Truenat® Malaria Pv-Pf (a new Q-PCR device for malaria testing by MolBio) over a 1-year period.
Project Description
This study is part of the POCTRN – Point of Care Technologies for Nutrition, Infection and Cancer for Global Health (PORTENT) programme and aims to improve early and accurate malaria diagnosis by evaluating point-of-care molecular diagnostic technologies suitable for low-resource and field settings. The study assesses the operational feasibility and diagnostic performance of a PoC Q-PCR–based malaria testing platform, including its integration into routine community workflows. By leveraging innovative diagnostics and healthcare worker training, it seeks to strengthen malaria surveillance and support malaria elimination efforts. The study is conducted at Swasthya Swaraj Community Hospital, with St. John’s Research Institute serving as the lead organization overseeing implementation. In addition, a pilot study is undertaken to assess operational feasibility and pathways for commercialization of the Truenat® Malaria Pv-Pf device for real-world healthcare use.
Project Duration
2024 - 2025
Project Lead
Dr Mary Dias
Authors
Dr Mary Dias,Dr Tony Raj, Dr Dhinagaran D, Dr Verghese Thomas, Dr. Bharat Kalidindi.Dr. Ryan Fernandes
Project Status
ongoing
Project Type
NIH–NIBIB POCTRN